Skip to main content
SpringerLink
Log in

The Fallacy of Amyloid and Cognition in Alzheimer’s Disease

  • Correspondence
  • Published:
Drugs & Aging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 2002; 297: 353–6

    Article  PubMed  CAS  Google Scholar 

  2. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968; 114: 797–811

    Article  PubMed  CAS  Google Scholar 

  3. Perry EK, Tomlinson BE, Blessed G, et al. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 1978; 2: 1457–9

    Article  PubMed  CAS  Google Scholar 

  4. Cummings BJ, Cotman CW. Image analysis of beta-amyloid load in Alzheimer’s disease and relation to dementia severity. Lancet 1995; 346: 1524–8

    Article  PubMed  CAS  Google Scholar 

  5. Saura CA, Chen G, Malkani S, et al. Conditional inactivation of presenilin 1 prevents amyloid accumulation and temporarily rescues contextual and spatial working memory impairments in amyloid precursor protein transgenic mice. J Neurosci 2005; 25(29): 6755–64

    Article  PubMed  CAS  Google Scholar 

  6. Dewachter I, Reverse D, Caluwaerts N, et al. Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice. J Neurosci 2002; 22(9): 3445–53

    PubMed  CAS  Google Scholar 

  7. Nunomura A, Chiba S, Lippa CF, et al. Neuronal RNA oxidation is a prominent feature of familial Alzheimer’s disease. Neurobiol Dis 2004; 17(1): 108–13

    Article  PubMed  CAS  Google Scholar 

  8. Nunomura A, Perry G, Aliev G, et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 2001; 60(8): 759–67

    PubMed  CAS  Google Scholar 

  9. Rottkamp CA, Atwood CS, Joseph JA, et al. The state versus amyloid-beta: the trial of the most wanted criminal in Alzheimer disease. Peptides 2002; 23(7): 1333–41

    Article  PubMed  CAS  Google Scholar 

  10. Lee HG, Casadesus G, Zhu X, et al. Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease. Ann NY Acad Sci 2004; 1019: 1–4

    Article  PubMed  CAS  Google Scholar 

  11. Perry G, Nunomura A, Raina AK, et al. Amyloid-beta junkies [letter]. Lancet 2000; 355(9205): 757

    Article  PubMed  CAS  Google Scholar 

  12. Smith MA, Atwood CS, Joseph JA, et al. Predicting the failure of amyloid-beta vaccine. Lancet 2002; 359(9320): 1864–5

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Work in the authors’ laboratories is supported by the John Douglas French Alzheimer’s Foundation and the National Institutes of Health (AG026151). The authors have no conflicts of interest that are directly relevant to the content of this article.

Author information

Authors and Affiliations

  1. Institute of Pathology, Case Western Reserve University, Cleveland, Ohio, USA

    Hyoung-gon Lee, Xiongwei Zhu, George Perry & Mark A. Smith

Authors
  1. Hyoung-gon Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiongwei Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. George Perry
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mark A. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, Hg., Zhu, X., Perry, G. et al. The Fallacy of Amyloid and Cognition in Alzheimer’s Disease. Drugs Aging 23, 179 (2006). https://doi.org/10.2165/00002512-200623020-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-200623020-00007

Keywords

Search

Navigation